A rapidly advancing area of biomedical innovation is shining a spotlight on miR-128-3p, a small yet powerful molecule with the potential to reshape how diseases—especially cancer—are detected, ...
Melanoma is one of the deadliest forms of skin cancer, due in large part to its ability to rapidly develop resistance to ...
A research team co-led by scientists at The Wistar Institute has combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively. The new approach, they ...
Morning Overview on MSN
A single molecule just shut down the gene behind the deadliest brain cancer in mice — and it did it without one harmful side effect
Glioblastoma kills roughly 10,000 Americans every year. Patients diagnosed with a recurrence after standard chemotherapy face a median survival measured in months, not years, and the drug they rely on ...
8h
Lung cancer cells can revert identity to a branching state, fueling resistance and aggressive growth
Oncologists have discovered that lung cancer cells can change their identity to resist treatment. Research published in ...
Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that ...
Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer ...
Morning Overview on MSN
McGill scientists just supercharged the body’s natural killer cells to punch through the walls tumors build to survive — restoring an immune defense cancer had switched off
Natural killer cells are supposed to be the immune system’s first responders against cancer. They don’t need to be trained on ...
A groundbreaking study may change how doctors treat glioblastoma, one of the deadliest brain cancers. Researchers Virginia Commonwealth University have developed a powerful new therapy using an ...
Cancer scientists have discovered that lung cancer cells can change their identity to resist treatment. Research published today [27 May] in Molecular Oncology reveals how lung cancer cells can become ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results